Inhaled Corticosteroid Exposure and Risk of Cataract in Patients with Asthma and COPD: A Systematic Review and Meta-Analysis.

Published in: Journal of ophthalmology (2023)

ICS treatment in asthma and COPD patients is a risk factor for cataract development. Our results emphasize a previously underestimated potential long-term risk of treatment with ICS and underline the importance of targeting ICS treatment, and not least dosing, to improve the risk-benefit ratio of maintenance treatment in both asthma and COPD.

Keyphrases

chronic obstructive pulmonary disease
lung function
end stage renal disease
cystic fibrosis
newly diagnosed
combination therapy
ejection fraction
climate change
risk assessment
patient reported